trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

All eye drops for dry eyes contain steroids

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 5 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that all eye drops for dry eyes contain steroids?

No. The claim that all eye drops for dry eye contain steroids is incorrect. Many common dry eye treatments, such as cyclosporine, diquafosol, and rebamipide, are non-steroidal.

Verdict: REFUTED · 0 sources for, 5 against · Last checked

The analysis

The claim asserts that all dry eye drops contain steroids. Multiple retrieved papers discuss non-steroidal treatments for dry eye disease, including cyclosporine, diquafosol, and rebamipide. Therefore, the claim is clearly false.

Evidence against · 5
2023
Get citation
Akpek, E., Wirta, D., Downing, J., Tauber, J., Sheppard, J., Ciolino, J., Meides, A. S., & Krösser, S. (2023). Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease. doi.org. https://doi.org/10.1001/jamaophthalmol.2023.0709

See more details
More against · 4
2022
Get citation
Messmer, E., Ahmad, S., Castillo, J. M. B. D., Mrukwa-Kominek, E., Rolando, M., Vitovska, O., & Baudouin, C. (2022). Management of inflammation in dry eye disease: Recommendations from a European panel of experts. doi.org. https://doi.org/10.1177/11206721221141481

2023
Get citation
Chan, Y. & Sun, C. (2023). Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen. doi.org. https://doi.org/10.4103/tjo.tjo-d-22-00140

2023
Get citation
Liu, S., Yang, G., Li, Q., & Tang, S. (2023). Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials. doi.org. https://doi.org/10.4103/ijo.ijo_268_23

2023
Get citation
Jain, K., Jaju, M., & Yadav, D. (2023). Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre. doi.org. https://doi.org/10.4103/ijo.ijo_2586_22

What does the evidence say?

The claim asserts that all dry eye drops contain steroids. Multiple retrieved papers discuss non-steroidal treatments for dry eye disease, including cyclosporine, diquafosol, and rebamipide. Therefore, the claim is clearly false.

Receipt History
first checked04 Aug 2026
judged → REFUTED · 1104 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work